Managing Counterparty Risk in OTC Derivatives
Managing Counterparty Risk in OTC Derivatives by Amol Dhargalkar, Director of Corporate Advisory Services, Chatham Financial Prior to early 2008, managing counterparty risk across derivatives was low on the list of factors that most firms considered in the hedging and risk management process. While always a discussion point, the fall of Bear Stearns, Lehman Brothers, […]


